tiprankstipranks
Advertisement
Advertisement

AU:NSB Stock Latest News

NeuroScientific Director Converts Performance Shares After SAS Milestone
Company AnnouncementsNeuroScientific Director Converts Performance Shares After SAS Milestone
6d ago
NSB
NeuroScientific Issues New ASX Securities Under Disclosure Exemption
PremiumCompany Announcements
NeuroScientific Issues New ASX Securities Under Disclosure Exemption
7d ago
NSB
Neuroscientific Biopharmaceuticals Seeks ASX Quotation for 57 Million New Shares
PremiumCompany Announcements
Neuroscientific Biopharmaceuticals Seeks ASX Quotation for 57 Million New Shares
7d ago
NSB
NeuroScientific Biopharmaceuticals outlines stem cell strategy for severe Crohn’s disease
PremiumCompany Announcements
NeuroScientific Biopharmaceuticals outlines stem cell strategy for severe Crohn’s disease
13d ago
NSB
NeuroScientific Seeks Trading Halt Ahead of Material Program Results
PremiumCompany Announcements
NeuroScientific Seeks Trading Halt Ahead of Material Program Results
14d ago
NSB
NeuroScientific advances StemSmart cell therapy with strong early Crohn’s data and scale-up plans
PremiumCompany AnnouncementsNeuroScientific advances StemSmart cell therapy with strong early Crohn’s data and scale-up plans
1M ago
NSB
NeuroScientific scales up StemSmart manufacturing with Q-Gen for Phase 2 trials
Premium
Company Announcements
NeuroScientific scales up StemSmart manufacturing with Q-Gen for Phase 2 trials
3M ago
NSB
NeuroScientific Revenue Surges but Half-Year Loss Deepens and Asset Base Shrinks
Premium
Company Announcements
NeuroScientific Revenue Surges but Half-Year Loss Deepens and Asset Base Shrinks
3M ago
NSB
NeuroScientific Advances StemSmart™ Program as Crohn’s Trial Prep Gathers Pace
PremiumCompany Announcements
NeuroScientific Advances StemSmart™ Program as Crohn’s Trial Prep Gathers Pace
4M ago
NSB
NeuroScientific’s StemSmart Therapy Delivers Strong Results in Fistulising Crohn’s Patients
PremiumCompany Announcements
NeuroScientific’s StemSmart Therapy Delivers Strong Results in Fistulising Crohn’s Patients
5M ago
NSB
NeuroScientific Biopharmaceuticals Advances Therapeutics for Crohn’s Disease and Neuroprotection
PremiumCompany Announcements
NeuroScientific Biopharmaceuticals Advances Therapeutics for Crohn’s Disease and Neuroprotection
7M ago
NSB
NeuroScientific Biopharmaceuticals to Host Investor Webinar on Strategic Advances
PremiumCompany Announcements
NeuroScientific Biopharmaceuticals to Host Investor Webinar on Strategic Advances
7M ago
NSB
NeuroScientific Advances StemSmart™ Therapy for Crohn’s Disease
PremiumCompany AnnouncementsNeuroScientific Advances StemSmart™ Therapy for Crohn’s Disease
7M ago
NSB
NeuroScientific Biopharmaceuticals Establishes Advisory Board to Drive Innovation
Premium
Company Announcements
NeuroScientific Biopharmaceuticals Establishes Advisory Board to Drive Innovation
7M ago
NSB
NeuroScientific Biopharmaceuticals Advances StemSmart™ for Crohn’s Disease with Strategic Appointments and Partnerships
Premium
Company Announcements
NeuroScientific Biopharmaceuticals Advances StemSmart™ for Crohn’s Disease with Strategic Appointments and Partnerships
7M ago
NSB
Neuroscientific Biopharmaceuticals Expands Manufacturing and Proves Clinical Efficacy
PremiumCompany Announcements
Neuroscientific Biopharmaceuticals Expands Manufacturing and Proves Clinical Efficacy
8M ago
NSB
NeuroScientific’s StemSmart™ Gains TGA Approval for Crohn’s Disease Treatment
PremiumCompany Announcements
NeuroScientific’s StemSmart™ Gains TGA Approval for Crohn’s Disease Treatment
8M ago
NSB
NeuroScientific Biopharmaceuticals Announces Annual General Meeting Details
PremiumCompany Announcements
NeuroScientific Biopharmaceuticals Announces Annual General Meeting Details
8M ago
NSB
NeuroScientific Biopharmaceuticals Announces Annual General Meeting
PremiumCompany Announcements
NeuroScientific Biopharmaceuticals Announces Annual General Meeting
8M ago
NSB
Neuroscientific Biopharmaceuticals Announces Change in Substantial Holding
PremiumCompany AnnouncementsNeuroscientific Biopharmaceuticals Announces Change in Substantial Holding
9M ago
NSB
NeuroScientific Biopharmaceuticals Announces AGM and Director Nomination Deadline
Premium
Company Announcements
NeuroScientific Biopharmaceuticals Announces AGM and Director Nomination Deadline
9M ago
NSB
Neuroscientific Biopharmaceuticals Issues New Equity Securities
Premium
Company Announcements
Neuroscientific Biopharmaceuticals Issues New Equity Securities
9M ago
NSB

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >